Postpartum hemorrhage (PPH) is the leading cause of preventable maternal death, yet it’s often unpredictable. Oli PPH, developed by Australian-based Baymatob, uses AI to identify high-risk pregnancies before labor begins. Recently granted FDA Breakthrough Device Designation, this technology has the potential to transform maternal care. To support its U.S. adoption, Baymatob partnered with Jump Simulation to explore how clinicians can seamlessly integrate Oli PPH into existing workflows. This is the kind of forward-thinking collaboration that drives better outcomes for women everywhere. See the significance: (fb)

💡 Spotlight on Innovation: Innovation Academic Incubator (IAI) 💡 IAI combines the talents of OSF HealthCare clinicians, faculty from our partner universities and researchers to develop novel health care solutions. Over the last 10 years, IAI has awarded more than $18.2 million to fund 237 projects, resulting in 140 publications and 12 patents. Swipe 👉 to explore IAI’s impressive results. Learn more about IAI and its impact: http://osf.care/yQAb50VLAKM (fb)